Onkologie. 2026:20(2):120-122 | DOI: 10.36290/xon.2026.023
Skin toxicity in the treatment of metastatic malignant melanoma with combination immunotherapy
- Komplexní onkologické centrum, Nemocnice Jihlava
Malignant melanoma is an oncological disease whose incidence has continued to rise in recent years (24.6 cases per 100,000 inhabitants for the period 2018-2022). The disease ratio of both men and women is close to 1 : 1. Although the incidence of the disease is rising, mortality remains stable, mainly attributable to the early diagnosis of the disease (1). Even so, we see a finding of primarily metastatic melanoma, as well as a portion of patients despite early diagnosis and established treatment metastasizing. In my case report, I describe a case of treatment of primarily metastatic melanoma with combination immunotherapy, where significant skin toxicity has occurred.
Keywords: malignant melanoma, checkpoint inhibitors, corticotherapy.
Accepted: April 20, 2026; Published: April 28, 2026 Show citation
References
- Portál epidemiologie novotvarů v ČR. Available from: https://www.svod.cz/. [cit.2025-10-01].
- Modrá Kniha České onkologické společnosti Online.31. Brno: Masarykův onkologický ústav; 2025. Available from: https://www.linkos.cz/files/modra-kniha/25.pdf. [cit.2025-10-01].
- Databáze léčiv dostupná na https://prehledy.sukl.cz/prehled_leciv.html#/. [cit.2025-10-01].
- Souhrn údajů o přípravcích Opdivo a Yervoy.
- Arenbergerová M, Pásek M, Arenberger P. Maligní melanom: diagnostika a léčba: na základě aktuálního doporučeného postupu. Praha: Maxdorf; 2024.
- Keilholz U, Ascierto PA, Dummer R, et al. ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee. Ann Oncol. 2020 Nov;31(11):1435-1448. doi: 10.1016/j.annonc.2020.07.004. Epub 2020 Aug 4. PMID: 32763453.
Go to original source... 
Go to PubMed...